Hemp oil containing cannabidiol (CBD) shows modest promise for managing arthritis pain in dogs, but the honest state of the science is that evidence remains thin. A 2023 systematic review pooling data from clinical trials found that CBD oil may reduce pain scores in dogs with osteoarthritis, but rated the certainty of that evidence as “very low.” That does not mean it doesn’t work. It means the studies so far have been small, short, and not always designed in ways that let researchers draw firm conclusions. What the research does suggest is that CBD-rich hemp extracts are reasonably safe for most dogs and produce real biological effects in their joints, even if the pain relief story is still being written.
Why CBD Has a Biological Basis in Canine Joints
One reason researchers keep studying hemp-derived CBD for dog arthritis is that dogs have the biological hardware to respond to it. The endocannabinoid system, a network of receptors involved in inflammation and pain signaling, is active in canine joint tissue. A study examining the hip and stifle (knee) joints of middle-aged dogs found that the synovial lining of both joints expressed all three major cannabinoid receptors, including in the immune cells that drive joint inflammation.1PubMed Central. Endocannabinoid System Receptors at the Hip and Stifle Joints of Middle-Aged Dogs: A Novel Target for the Therapeutic Use of Cannabis sativa Extract in Canine Arthropathies These receptors were present even in dogs without obvious signs of arthritis, suggesting the system is primed and available for intervention rather than something that only appears once disease has set in.
The anti-inflammatory angle is where the mechanistic case gets strongest. Lab and mouse-model experiments have shown that CBD dials down key inflammatory molecules while boosting anti-inflammatory ones.2PubMed Central. A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain That matters because osteoarthritis is fundamentally an inflammatory disease. Cartilage wears down, the joint lining gets irritated, immune cells swarm in, and the resulting chemical cascade causes pain and stiffness. If CBD can calm that cascade, even partially, you’d expect some clinical benefit. Whether that lab-bench promise translates to a dog getting up more easily from a nap is the harder question.
What the Clinical Trials Actually Show
Several controlled trials have tested CBD-rich hemp oil in dogs with naturally occurring osteoarthritis, and the results are genuinely encouraging on subjective measures. In one trial using an oral CBD oil as part of a pain management regimen, dogs receiving CBD had significantly lower pain severity and pain interference scores than control dogs at multiple time points over 12 weeks, and their owners rated quality of life higher.3PubMed Central. Oral Transmucosal Cannabidiol Oil Formulation as Part of a Multimodal Analgesic Regimen: Effects on Pain Relief and Quality of Life Improvement in Dogs Affected by Spontaneous Osteoarthritis Another prospective study comparing CBD to placebo in dogs with mobility disorders found that CBD-treated dogs showed improvement in veterinary assessments, owner-reported pain severity, and behavior-based pain scoring.4PubMed Central. Evaluation of the effect of cannabidiol administration with and without nonsteroidal anti-inflammatory drugs in dogs with mobility disorders: a prospective, double-blind, crossover, placebo-controlled study
The problem is that when researchers looked at objective measures of improvement, like force-plate gait analysis (which measures how much weight a dog actually puts on a limb), the results were less convincing. That same prospective study found insufficient evidence that CBD improved percent body weight distribution on the affected limb, even as the subjective scores improved.4PubMed Central. Evaluation of the effect of cannabidiol administration with and without nonsteroidal anti-inflammatory drugs in dogs with mobility disorders: a prospective, double-blind, crossover, placebo-controlled study The systematic review and meta-analysis that pooled data from three studies found trend-level reductions in both pain severity and pain interference scores with CBD, but neither reached statistical significance, and the overall certainty of the evidence was rated very low.5PubMed Central. Efficacy and safety of cannabidiol for the treatment of canine osteoarthritis: a systematic review and meta-analysis of animal intervention studies
So the picture is something like: owners and veterinarians consistently report that dogs seem to feel better on CBD, but the tools that measure physical function without relying on human judgment don’t always agree. That gap matters, and it has a name.
The Caregiver Placebo Effect Is Bigger Than You Think
If you give a dog owner a pill to give their arthritic dog and tell them it might help, roughly four out of ten owners will report improvement even when the pill is a sugar tablet. A study specifically examining this phenomenon found that the caregiver placebo effect for lameness in dogs occurred about 40% of the time among owners, and at similar rates among veterinarians evaluating dogs at a walk or trot. Meanwhile, actual ground reaction forces measured by force plates showed no change during placebo treatment.6PubMed. Caregiver placebo effect for dogs with lameness from osteoarthritis The effect also got stronger over time, meaning the longer an owner gave the placebo, the more convinced they became that it was working.
This doesn’t mean CBD is a placebo. But it does mean that owner-reported improvements in any supplement trial have to be interpreted carefully. The prospective crossover study mentioned earlier noted that dogs in its placebo group showed some subjective improvements compared to baseline, confirming that caregiver expectations played a role, though the CBD group still outperformed placebo on several measures.4PubMed Central. Evaluation of the effect of cannabidiol administration with and without nonsteroidal anti-inflammatory drugs in dogs with mobility disorders: a prospective, double-blind, crossover, placebo-controlled study The takeaway for dog owners is to be honest with yourself about what you’re observing. Track specific behaviors, like whether your dog can make it up the stairs without pausing, or how long their morning stiffness lasts, rather than relying on a general feeling that they seem peppier.
Safety Profile and Liver Enzyme Changes
The reassuring finding across multiple studies is that CBD-rich hemp extracts appear well-tolerated by most dogs over weeks to months. Dogs don’t typically show obvious signs of distress, GI upset, or behavioral changes at commonly studied doses. But there is one consistent laboratory finding that every dog owner considering CBD should know about: it reliably raises alkaline phosphatase (ALP), a liver enzyme, above normal reference ranges.
In a six-month daily feeding study, over half the dogs receiving CBD showed ALP levels above the clinical reference range, while none of the placebo dogs did. The elevations were statistically significant at every measured time point. The good news is that all values returned to baseline after a four-week washout period, and other markers of liver function remained normal throughout.7PubMed Central. Long-term daily feeding of cannabidiol is well-tolerated by healthy dogs A separate long-term study testing higher doses of CBD found the same pattern: ALP went up significantly in CBD-treated dogs, while ALT (a more specific marker of liver damage) stayed within normal range for all groups.8PubMed Central. Tolerability of long‐term cannabidiol supplementation to healthy adult dogs
What this means practically is that if your vet runs blood work and finds elevated ALP while your dog is taking a CBD product, it may be the supplement and not liver disease. But you can’t simply assume that. ALP can rise for many reasons, some of them serious, especially in older dogs already prone to conditions like Cushing’s disease or liver tumors. If your dog is on CBD, your vet needs to know so they can interpret blood work in context. Periodic monitoring is sensible for any dog on long-term supplementation.
Drug Interactions Worth Knowing About
CBD is processed through the liver by the same enzyme pathways that metabolize certain drugs, which creates the possibility of interactions. Lab studies using dog liver tissue found that both CBD and CBDA (cannabidiolic acid, another compound in hemp) inhibited enzymes responsible for breaking down tramadol, a pain medication commonly prescribed for arthritic dogs.9PubMed. Cannabidiol and cannabidiolic acid: Preliminary in vitro evaluation of metabolism and drug-drug interactions involving canine cytochrome P-450, UDP-glucuronosyltransferase, and P-glycoprotein In practical terms, this means giving CBD alongside tramadol could cause tramadol to linger in your dog’s system at higher-than-expected levels, potentially increasing side effects like sedation or GI upset.
These findings are from lab dishes, not live dogs, so the real-world magnitude of the interaction isn’t established. But the caution extends beyond tramadol. NSAIDs (like carprofen or meloxicam) are the most common class of prescription drugs for canine arthritis, and the question of how CBD interacts with them is still being explored. One clinical trial specifically tested CBD in combination with NSAIDs and found improvements without obvious safety signals, but this was a short study with a limited number of dogs.4PubMed Central. Evaluation of the effect of cannabidiol administration with and without nonsteroidal anti-inflammatory drugs in dogs with mobility disorders: a prospective, double-blind, crossover, placebo-controlled study If your dog is on any prescription medications, talk to your vet before adding hemp oil to the mix.
Feeding Your Dog Changes How Much CBD Gets Absorbed
How you give your dog CBD matters almost as much as the dose you pick. CBD is fat-soluble, and whether your dog has eaten recently has a dramatic effect on how much of it actually reaches the bloodstream. A pilot study comparing fasted and fed dogs found that giving CBD with food increased the peak blood concentration by roughly six-fold and total absorption by about ten-fold compared to fasting.10PubMed. Comparative plasma exposure and fecal excretion of oral cannabidiol in fasted and fed dogs: pilot study An earlier study found the opposite direction of effect, with fasted dogs showing higher peak concentrations but lower overall absorption,11PubMed. Pharmacokinetics of Bedrocan®, a cannabis oil extract, in fasting and fed dogs: An explorative study though the two studies used different formulations and doses, which likely explains the discrepancy.
The practical upshot is that giving CBD oil with or on top of a meal (especially one containing some fat) is the safest bet for consistent absorption. If you sometimes give it on an empty stomach and sometimes with dinner, you’re effectively giving your dog wildly different doses without changing the dropper amount. Consistency matters. The formulation itself also plays a role: a pharmacokinetic study comparing soft gel capsules to oil found that soft gels led to higher peak concentrations of certain cannabinoids, and dogs accepted the capsules more readily than oil dripped into their mouths.12Medical Research Archives. Twenty-Four Hour and One-Week Steady State Pharmacokinetics of Cannabinoids in Two Formulations of Cannabidiol and Cannabidiolic Acid Rich Hemp in Dogs
Product Quality Is All Over the Map
Here is where the practical reality for dog owners gets frustrating. There are no licensed veterinary CBD products on the market. Not one. A review of the regulatory landscape found that the absence of appropriate testing data means no CBD product has achieved the level of quality assurance required for a licensed veterinary medicine.13PubMed Central. CBD for pets: navigating quality assurance, safety standards, and marketing strategies Everything available is sold as a supplement or treat, which means it doesn’t go through the same regulatory scrutiny as a prescription drug.
The consequences of that gap are measurable. An independent analysis of 29 over-the-counter veterinary hemp supplements found that only about a third had cannabinoid concentrations within 10% of what their labels claimed. The median product contained 93% of the labeled amount, but individual products ranged wildly, from 0% to 154% of their claims. Heavy metal contamination was detected in four of the 29 products, with lead being the most common contaminant.14PubMed Central. Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements About three-quarters of tested products could provide a certificate of analysis from a third-party lab, which is better than nothing but still means roughly a quarter couldn’t or didn’t.
If you decide to try hemp oil for your dog, the certificate of analysis is non-negotiable. Look for one from an independent (not in-house) laboratory that lists cannabinoid concentrations, THC content (which should be below 0.3% in hemp-derived products and ideally negligible), and results for heavy metals and pesticides. A company that won’t share a current COA on request is a company you shouldn’t buy from.
Hemp Seed Oil vs. CBD Hemp Extract
A common source of confusion is the difference between hemp seed oil and CBD-rich hemp extract, which are sometimes both labeled simply as “hemp oil.” Hemp seed oil is pressed from the seeds of the cannabis plant. It’s nutritious, rich in omega-3 and omega-6 fatty acids, but contains little to no CBD. It’s a reasonable dietary supplement for skin and coat health, but there is no mechanistic reason to expect it to help with arthritis pain specifically.
CBD-rich hemp extract, by contrast, is derived from the flowers, leaves, and stalks of the plant, where the cannabinoids are concentrated. When the research discussed in this article refers to hemp oil helping with arthritis, it’s referring to this type of product, usually described as “full-spectrum CBD oil” or “broad-spectrum CBD oil.” Full-spectrum means it includes not just CBD but a range of other cannabinoids and plant compounds, including trace amounts of THC (below the legal 0.3% threshold). Broad-spectrum means THC has been removed. If a product’s label says “hemp oil” but doesn’t specify a CBD concentration in milligrams, you’re probably looking at hemp seed oil, not the kind studied in arthritis trials.
What About THC and Dogs
Dogs are more sensitive to tetrahydrocannabinol (THC) than humans are. Even small amounts can cause lethargy, wobbliness, dilated pupils, urinary incontinence, and in more serious cases, vomiting or prolonged sedation. This is why the hemp-derived products used in research contain only trace amounts of THC, typically well under 0.3%. At the doses used in clinical studies, THC-related toxicity has not been a reported concern.
That said, “hemp oil” products bought online or in pet stores are not always what they claim. The product quality analysis cited earlier found wild variability in cannabinoid content.14PubMed Central. Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements A product that is supposed to contain negligible THC might contain more than expected if the manufacturer’s quality control is poor. This is another reason that third-party testing matters, especially for dogs. When a dosing study measured serum cannabinoids in dogs receiving a CBD- and CBDA-rich hemp extract, THC and THCA were among the detectable compounds, though they cleared during washout periods.15PubMed Central. Tolerability of 2 and 4 mg/kg Dosing Every 12 Hour of a Cannabidiol- and Cannabidiolic Acid-Rich Hemp Extract on Mixed-Breed Dogs Utilized for Teaching in a Closed Colony The point isn’t that these products are dangerous at normal doses. The point is that “normal doses” assumes accurate labeling, and you can’t take that for granted.
How This Fits Alongside Conventional Arthritis Treatment
No veterinary researcher studying CBD is suggesting it should replace established arthritis treatments like NSAIDs, physical rehabilitation, weight management, or joint surgery when indicated. The question is whether it has a role as an add-on, particularly for dogs that can’t tolerate NSAIDs well or whose pain isn’t fully controlled by conventional therapy alone.
One randomized trial specifically looked at this question by combining CBD with existing NSAID treatment in dogs with mobility disorders. The researchers found that adding CBD improved pain severity scores and behavioral pain measures beyond what the dogs’ existing regimen achieved alone.4PubMed Central. Evaluation of the effect of cannabidiol administration with and without nonsteroidal anti-inflammatory drugs in dogs with mobility disorders: a prospective, double-blind, crossover, placebo-controlled study A separate trial that used CBD oil alongside a multimodal pain management plan (not just drugs) also reported lower pain scores and better quality-of-life ratings in CBD-treated dogs over several weeks.3PubMed Central. Oral Transmucosal Cannabidiol Oil Formulation as Part of a Multimodal Analgesic Regimen: Effects on Pain Relief and Quality of Life Improvement in Dogs Affected by Spontaneous Osteoarthritis These are small studies, but the direction is consistent: CBD seems to add something on top of standard care, at least for subjective pain endpoints.
The doses used across studies have typically ranged from about 2 mg/kg to 5 mg/kg of body weight per day, often split into two doses. There is no universally agreed-upon optimal dose, and individual dogs absorb and metabolize CBD differently. Starting low and increasing gradually while watching for side effects like soft stool or excessive sleepiness is the standard veterinary advice. Given the ALP elevation issue, a baseline blood panel before starting supplementation, followed by a recheck after a few weeks, is a reasonable precaution most vets would endorse.